PIK-75 was developed as part of a PI 3-kinase drug discovery program. PIK75 attenuates insulin stimulation of Akt/PKB in a range of cell types at 100 nM.
For research use only. We do not sell to patients.
| Name | PIK-75 |
|---|---|
| Iupac Chemical Name | (E)-N'-((6-bromoimidazo[1,2-a]pyridin-3-yl)methylene)-N,2-dimethyl-5-nitrobenzenesulfonohydrazide |
| Synonyms | PIK75; PIK-75; PIK 75 |
| Molecular Formula | C16H14BrN5O4S |
| Molecular Weight | 452.283 |
| Smile | BrC=1C=CC=2N(C1)C(=CN2)\C=N\N(S(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])C)C |
| InChiKey | QTHCAAFKVUWAFI-DJKKODMXSA-N |
| InChi | InChI=1S/C16H14BrN5O4S/c1-11-3-5-13(22(23)24)7-15(11)27(25,26)20(2)19-9-14-8-18-16-6-4-12(17)10-21(14)16/h3-10H,1-2H3/b19-9+ |
| CAS Number | 372196-67-3 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | off-white solid |
|---|---|
| Purity | 98% |
| Storage | 3 years -20ºCpowder |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |